验证因果效应估计值的两步框架

IF 2.4 4区 医学 Q3 PHARMACOLOGY & PHARMACY Pharmacoepidemiology and Drug Safety Pub Date : 2024-09-10 DOI:10.1002/pds.5873
Lingjie Shen, Erik Visser, Felice van Erning, Gijs Geleijnse, Maurits Kaptein
{"title":"验证因果效应估计值的两步框架","authors":"Lingjie Shen, Erik Visser, Felice van Erning, Gijs Geleijnse, Maurits Kaptein","doi":"10.1002/pds.5873","DOIUrl":null,"url":null,"abstract":"Background: Comparing causal effect estimates obtained using observational data to those obtained from the gold standard (i.e., randomized controlled trials [RCTs]) helps assess the validity of these estimates. However, comparisons are challenging due to differences between observational data and RCT generated data. The unknown <jats:italic>treatment assignment</jats:italic> <jats:italic>mechanism</jats:italic> in the observational data and varying <jats:italic>sampling mechanisms</jats:italic> between the RCT and the observational data can lead to confounding and sampling bias, respectively.Aims: The objective of this study is to propose a two‐step framework to validate causal effect estimates obtained from observational data by adjusting for both mechanisms.Materials and Methods: An estimator of causal effects related to the two mechanisms is constructed. A two‐step framework for comparing causal effect estimates is derived from the estimator. An R package <jats:italic>RCTrep</jats:italic> is developed to implement the framework in practice.Results: A simulation study is conducted to show that using our framework observational data can produce causal effect estimates similar to those of an RCT. A real‐world application of the framework to validate treatment effects of adjuvant chemotherapy obtained from registry data is demonstrated.Conclusion: This study constructs a framework for comparing causal effect estimates between observational data and RCT data, facilitating the assessment of the validity of causal effect estimates obtained from observational data.","PeriodicalId":19782,"journal":{"name":"Pharmacoepidemiology and Drug Safety","volume":"35 1","pages":"e5873"},"PeriodicalIF":2.4000,"publicationDate":"2024-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"A Two‐Step Framework for Validating Causal Effect Estimates\",\"authors\":\"Lingjie Shen, Erik Visser, Felice van Erning, Gijs Geleijnse, Maurits Kaptein\",\"doi\":\"10.1002/pds.5873\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Background: Comparing causal effect estimates obtained using observational data to those obtained from the gold standard (i.e., randomized controlled trials [RCTs]) helps assess the validity of these estimates. However, comparisons are challenging due to differences between observational data and RCT generated data. The unknown <jats:italic>treatment assignment</jats:italic> <jats:italic>mechanism</jats:italic> in the observational data and varying <jats:italic>sampling mechanisms</jats:italic> between the RCT and the observational data can lead to confounding and sampling bias, respectively.Aims: The objective of this study is to propose a two‐step framework to validate causal effect estimates obtained from observational data by adjusting for both mechanisms.Materials and Methods: An estimator of causal effects related to the two mechanisms is constructed. A two‐step framework for comparing causal effect estimates is derived from the estimator. An R package <jats:italic>RCTrep</jats:italic> is developed to implement the framework in practice.Results: A simulation study is conducted to show that using our framework observational data can produce causal effect estimates similar to those of an RCT. A real‐world application of the framework to validate treatment effects of adjuvant chemotherapy obtained from registry data is demonstrated.Conclusion: This study constructs a framework for comparing causal effect estimates between observational data and RCT data, facilitating the assessment of the validity of causal effect estimates obtained from observational data.\",\"PeriodicalId\":19782,\"journal\":{\"name\":\"Pharmacoepidemiology and Drug Safety\",\"volume\":\"35 1\",\"pages\":\"e5873\"},\"PeriodicalIF\":2.4000,\"publicationDate\":\"2024-09-10\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Pharmacoepidemiology and Drug Safety\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1002/pds.5873\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pharmacoepidemiology and Drug Safety","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1002/pds.5873","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

摘要

背景:将使用观察数据获得的因果效应估计值与黄金标准(即随机对照试验 [RCT])获得的估计值进行比较,有助于评估这些估计值的有效性。然而,由于观察数据与随机对照试验产生的数据之间存在差异,因此比较具有挑战性。观察数据中未知的治疗分配机制和 RCT 与观察数据之间不同的抽样机制会分别导致混杂和抽样偏差。研究目的:本研究旨在提出一个两步框架,通过调整这两种机制来验证从观察数据中获得的因果效应估计值:构建与两种机制相关的因果效应估计值。根据该估计器推导出比较因果效应估计值的两步框架。为在实践中实施该框架,开发了一个 RCTrep 软件包:进行了一项模拟研究,表明使用我们的框架,观察数据可以产生与 RCT 类似的因果效应估计值。结果:一项模拟研究表明,利用我们的框架,观察数据可以得出与 RCT 类似的因果效应估计值。该框架在现实世界中的应用,验证了从登记数据中获得的辅助化疗的治疗效果:本研究构建了一个框架,用于比较观察数据和 RCT 数据之间的因果效应估计值,有助于评估从观察数据中获得的因果效应估计值的有效性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
A Two‐Step Framework for Validating Causal Effect Estimates
Background: Comparing causal effect estimates obtained using observational data to those obtained from the gold standard (i.e., randomized controlled trials [RCTs]) helps assess the validity of these estimates. However, comparisons are challenging due to differences between observational data and RCT generated data. The unknown treatment assignment mechanism in the observational data and varying sampling mechanisms between the RCT and the observational data can lead to confounding and sampling bias, respectively.Aims: The objective of this study is to propose a two‐step framework to validate causal effect estimates obtained from observational data by adjusting for both mechanisms.Materials and Methods: An estimator of causal effects related to the two mechanisms is constructed. A two‐step framework for comparing causal effect estimates is derived from the estimator. An R package RCTrep is developed to implement the framework in practice.Results: A simulation study is conducted to show that using our framework observational data can produce causal effect estimates similar to those of an RCT. A real‐world application of the framework to validate treatment effects of adjuvant chemotherapy obtained from registry data is demonstrated.Conclusion: This study constructs a framework for comparing causal effect estimates between observational data and RCT data, facilitating the assessment of the validity of causal effect estimates obtained from observational data.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
4.80
自引率
7.70%
发文量
173
审稿时长
3 months
期刊介绍: The aim of Pharmacoepidemiology and Drug Safety is to provide an international forum for the communication and evaluation of data, methods and opinion in the discipline of pharmacoepidemiology. The Journal publishes peer-reviewed reports of original research, invited reviews and a variety of guest editorials and commentaries embracing scientific, medical, statistical, legal and economic aspects of pharmacoepidemiology and post-marketing surveillance of drug safety. Appropriate material in these categories may also be considered for publication as a Brief Report. Particular areas of interest include: design, analysis, results, and interpretation of studies looking at the benefit or safety of specific pharmaceuticals, biologics, or medical devices, including studies in pharmacovigilance, postmarketing surveillance, pharmacoeconomics, patient safety, molecular pharmacoepidemiology, or any other study within the broad field of pharmacoepidemiology; comparative effectiveness research relating to pharmaceuticals, biologics, and medical devices. Comparative effectiveness research is the generation and synthesis of evidence that compares the benefits and harms of alternative methods to prevent, diagnose, treat, and monitor a clinical condition, as these methods are truly used in the real world; methodologic contributions of relevance to pharmacoepidemiology, whether original contributions, reviews of existing methods, or tutorials for how to apply the methods of pharmacoepidemiology; assessments of harm versus benefit in drug therapy; patterns of drug utilization; relationships between pharmacoepidemiology and the formulation and interpretation of regulatory guidelines; evaluations of risk management plans and programmes relating to pharmaceuticals, biologics and medical devices.
期刊最新文献
Core Concepts in Pharmacoepidemiology: New-User Designs. Determining Line of Therapy from Real-World Data in Non-Small Cell Lung Cancer. Handling With Vaccine Type Missing Data in a Dynamic Cohort to Assess the Link Between Time-Varying Vaccination and an Autoimmune Disease. Impact of Regulatory Risk Communication on Thrombosis With Thrombocytopenia Syndrome for COVID-19 Adenovirus Vector Vaccines on European Healthcare Professionals. Validity of Pharmaceutical Claims Data for Determining Medication Exposure in Long-Term Care Facilities.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1